Table 1.
Summary of the demographic data and other basic characteristics among benign versus malignant 110 conjunctival lesions
| Characteristic | All (n = 110) n (%) | Benign (n = 100) n (%) | Malignant (n = 10) n (%) | p value |
|---|---|---|---|---|
| Age of presentation (years) Median (IQR) | 53.0 (27.0–66.0) | 52.5 (26.0–65.8) | 53.0 (43.5–74.0) | 0.120 |
| Gender | ||||
| Male | 67 (60.9) | 62 (62.0) | 5 (50.0) | 0.458 |
| Female | 43 (39.1) | 38 (38.0) | 5 (50.0) | |
| Age at surgery (years) Median (IQR) | 53.0 (27.0–66.5) | 52.5 (26.0–66.0) | 53.0 (43.5–74.8) | 0.318 |
| Age group | ||||
| Children (≤ 16 years) | 18 (16.4) | 18 (18.0) | 0 (0.0) | 0.142 |
| Adults (> 16 years) | 92 (83.6) | 82 (82.0) | 10 (100) | |
| Bilateral | ||||
| Yes | 17 (15.5) | 17 (17.0) | 0 (0.0) | 0.156 |
| No | 93 (84.5) | 83 (83.0) | 10 (100) | |
| Duration of symptoms (months) Median (IQR) | 1.8 (0.2–11.9) | 2.1 (0.2–12.3) | 0.6 (0.06–6.4) | 0.036* |
| Duration of Follow-up (months) Median (IQR) | 2.8 (0.5–13.7) | 2.9 (0.6–14.3) | 1.3 (0.03–6.5) | 0.261 |
| Clinical diagnosis matching the histopathological diagnosis | ||||
| Yes | 83 (75.5) | 77 (77.0) | 6 (60.0) | NA |
| No | 27 (24.5) | 23 (23.0) | 4 (40.0) | NA |
*Statistically significant at 5% level of significance